{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T13:14:37Z","timestamp":1756991677625},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1982,1,1]],"date-time":"1982-01-01T00:00:00Z","timestamp":378691200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1982]]},"DOI":"10.1007\/bf00542321","type":"journal-article","created":{"date-parts":[[2004,11,18]],"date-time":"2004-11-18T17:53:34Z","timestamp":1100800414000},"page":"373-377","source":"Crossref","is-referenced-by-count":10,"title":["Pharmacokinetics of propranolol and sotalol in hyperthyroidism"],"prefix":"10.1007","volume":"21","author":[{"given":"A.","family":"Aro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Anttila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Korhonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2165\/00003088-197601050-00002","volume":"1","author":"M Eichelbaum","year":"1976","unstructured":"Eichelbaum M (1976) Drug metabolism in thyroid disease. Clin Pharmacokinet 1: 339?350","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl 4","key":"CR2","first-page":"157","volume":"52","author":"DG McDevitt","year":"1976","unstructured":"McDevitt DG (1976) Propranolol in the treatment of thyrotoxicosis: a review. Postgrad Med J 52 (Suppl 4): 157?161","journal-title":"Postgrad Med J"},{"key":"CR3","doi-asserted-by":"crossref","unstructured":"Feely J, Crooks J, Stevenson IH (1979) Altered pharmacokinetics of propranolol in hyperthyroidism. Br J Clin Pharmacol 8: 387P","DOI":"10.1111\/j.1365-2125.1979.tb04734.x"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/clpt.1980.204","volume":"28","author":"JG Riddell","year":"1980","unstructured":"Riddell JG, Neill JD, Kelly JG, McDevitt DG (1980) Effects of thyroid dysfunction on propranolol kinetics. Clin Pharmacol Ther 28: 565?574","journal-title":"Clin Pharmacol Ther"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1136\/bmj.2.6088.681-a","volume":"2","author":"J Feely","year":"1977","unstructured":"Feely J, Hamilton WFD, Forrest AL, Stevenson IH, Gunn A, Crooks J (1977) Beta-blocking drugs and thyroid function. Br Med J 2: 1352","journal-title":"Br Med J"},{"key":"CR6","first-page":"671","volume":"297","author":"R Hellman","year":"1977","unstructured":"Hellman R, Kelly KL, Mason WD (1977) Propranolol for thyroid storm. N Engl J Med 297: 671?672","journal-title":"N Engl J Med"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJM197902153000707","volume":"300","author":"S Rubenfeld","year":"1979","unstructured":"Rubenfeld S, Silverman VE, Welch KMA, Mallette LE, Kohler PO (1979) Variable plasma propranolol levels in thyrotoxicosis. N Engl J Med 300: 353?354","journal-title":"N Engl J Med"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/clpt.1980.128","volume":"28","author":"J Feely","year":"1980","unstructured":"Feely J, Stevenson IH, Crooks J (1980) Propranolol dynamics in thyrotoxicosis. Clin Pharmacol Ther 28: 40?44","journal-title":"Clin Pharmacol Ther"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cpt1970111112","volume":"11","author":"DG Shand","year":"1970","unstructured":"Shand DG, Nuckolls EM, Oates JA (1970) Plasma propranolol levels in adults. With observations in four children. Clin Pharmacol Ther 11: 112?120","journal-title":"Clin Pharmacol Ther"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/jps.2600600607","volume":"60","author":"ER Garrett","year":"1971","unstructured":"Garrett ER, Schnelle K (1971) Separation and spectrofluorometric assay of the beta-adrenergic blocker sotalol from blood and urine. J Pharm Sci 60: 833?839","journal-title":"J Pharm Sci"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/cpt1974163part1465","volume":"16","author":"H Sundquist","year":"1974","unstructured":"Sundquist H, Anttila M, Arstila M (1974) Antihypertensive effects of practolol and sotalol. Clin Pharmacol Ther 16: 465?472","journal-title":"Clin Pharmacol Ther"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJM197510022931406","volume":"293","author":"DW Greenblatt","year":"1975","unstructured":"Greenblatt DW, Koch-Weser J (1975) Clinical pharmacokinetics. N Engl J Med 293: 702?705","journal-title":"N Engl J Med"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2165\/00003088-197904020-00001","volume":"4","author":"PA Routledge","year":"1979","unstructured":"Routledge PA, Shand DG (1979) Clinical pharmacokinetics of propranolol. Clin Pharmacokinet 4: 73?90","journal-title":"Clin Pharmacokinet"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-0773.1976.tb03162.x","volume":"39","author":"M Anttila","year":"1976","unstructured":"Anttila M, Arstila M, Pfeffer M, Tikkanen R, Vallinkoski V, Sundquist H (1976) Human pharmacokinetics of sotalol. Acta Pharmacol Toxico (Kbh) 39: 118?128","journal-title":"Acta Pharmacol Toxico"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"875","DOI":"10.7326\/0003-4819-74-6-875","volume":"74","author":"W Grossman","year":"1971","unstructured":"Grossman W, Robin NI, Johnson LW, Brooks H, Selenkow HA, Dexter L (1971) Effects of beta blockade on the peripheral manifestations of thyrotoxicosis. Ann Intern Med 74: 875?879","journal-title":"Ann Intern Med"},{"key":"CR16","first-page":"46","volume-title":"Advances in beta adrenergic therapy: sotalol, vol 5","author":"I Ramsay","year":"1974","unstructured":"Ramsay I (1974) Sotalol and oxprenolol in hyperthyroidism. In: Smart AG (ed) Advances in beta adrenergic therapy: sotalol, vol 5. Excerpta Medica, Amsterdam, pp 46?55"},{"key":"CR17","first-page":"415","volume":"8","author":"P Wahlberg","year":"1976","unstructured":"Wahlberg P, Wennstr\u00f6m J, Ekelund P (1976) Control of thyrotoxicosis with sotalol. Ann Clin Res 8: 415?417","journal-title":"Ann Clin Res"},{"key":"CR18","unstructured":"Rubenfeld S, Silverman VE, Welch KMA, Mallette LE, Kohler PO (1978) Propranolol pharmacokinetics in thyrotoxicosis. Clin Res 26: 295A"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/ki.1974.119","volume":"6","author":"SE Bradley","year":"1974","unstructured":"Bradley SE, St\u00e9phan F, Coelho JB, R\u00e9ville P (1974) The thyroid and the kidney. Kidney Int 6: 346?365","journal-title":"Kidney Int"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2125.1977.tb00672.x","volume":"4","author":"JM Bell","year":"1977","unstructured":"Bell JM, Russell CJ, Nelson JK, Kelly JG, McDevitt DG (1977) Studies of the effect of thyroid dysfunction on the elimination of ?-adrenoceptor blocking drugs. Br J Clin Pharmacol 4: 79?81","journal-title":"Br J Clin Pharmacol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2265.1976.tb03872.x","volume":"5","author":"WJ Irvine","year":"1976","unstructured":"Irvine WJ, Toft AD (1976) The diagnostis and treatment of thyrotoxicosis. Clin Endocrinol (Oxf) 5: 687?707","journal-title":"Clin Endocrinol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM197702032960509","volume":"296","author":"M Eriksson","year":"1977","unstructured":"Eriksson M, Rubenfeld S, Garber AJ, Kohler PO (1977) Propranolol does not prevent thyroid storm. N Engl J Med 296: 263?264","journal-title":"N Engl J Med"},{"key":"CR23","first-page":"715","volume":"141","author":"JG Ljunggren","year":"1975","unstructured":"Ljunggren JG, Persson B (1975) Preoperative treatment of thyrotoxicosis with a beta-adrenergic blocking agent. Acta Chir Scand 141: 715?718","journal-title":"Acta Chir Scand"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1530\/acta.0.0960321","volume":"96","author":"A Aro","year":"1981","unstructured":"Aro A, Huttunen JK, Lamberg B-A, Pelkonen R, Ikkala E, Kuusisto A, Rissanen V, Salmi J, Tervonen S (1981) Comparison of propranolol and carbimazole as adjuncts to iodine-131 therapy of hyperthyroidism. Acta Endocrinol (Kbh) 96: 321?327","journal-title":"Acta Endocrinol"},{"key":"CR25","first-page":"41","volume":"2","author":"DG Shand","year":"1977","unstructured":"Shand DG (1977) Pharmacokinetic properties of the ?-adrenoreceptor blocking drugs. Cardiovasc Drugs 2: 41?54","journal-title":"Cardiovasc Drugs"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2265.1979.tb02111.x","volume":"10","author":"J Feely","year":"1979","unstructured":"Feely J, Isles TE, Ratcliffe WA, Crooks J (1979) Propranolol, triiodothyronine, reverse triiodothyronine and thyroid disease. Clin Endocrinol (Oxf) 10: 531?538","journal-title":"Clin Endocrinol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2265.1977.tb03322.x","volume":"6","author":"G Lotti","year":"1977","unstructured":"Lotti G, Delitala G, Devilla L, Alagna S, Masala A (1977) Reduction of plasma triiodothyronine (T3) induced by propranolol. Clin Endocrinol (Oxf) 6: 405?410","journal-title":"Clin Endocrinol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1210\/jcem-44-5-1002","volume":"44","author":"RP Verhoeven","year":"1977","unstructured":"Verhoeven RP, Visser TJ, Docter R, Henneman G, Schalekamp MA (1977) Plasma thyroxine, 3,3?, 5-tri-iodothyronine and 3,3?, 5?-tri-iodothyronine during ?-adrenergic blockade in hyperthyroidism. J Clin Endocrinol Metab 44: 1002?1005","journal-title":"J Clin Endocrinol Metab"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2265.1980.tb03394.x","volume":"13","author":"MK Jones","year":"1980","unstructured":"Jones MK, John R, Jones GR (1980) The effects of oxprenolol, acebutolol and propranolol on thyroid hormones in hyperthyroid subjects. Clin Endocrinol (Oxf) 13: 343?347","journal-title":"Clin Endocrinol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2125.1979.tb01048.x","volume":"8","author":"LE Murchison","year":"1979","unstructured":"Murchison LE, How J, Bewsher PD (1979) Comparison of propranolol and metoprolol in the management of hyperthyroidism. Br J Clin Pharmacol 8: 581?587","journal-title":"Br J Clin Pharmacol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.0954-6820.1979.tb13463.x","volume":"206","author":"OR Nilsson","year":"1979","unstructured":"Nilsson OR, Karlberg BE, K\u00e5gedal B, Tegler L, Almqvist S (1979) Non-selective and selective ?-1-adrenoceptor blocking agents in the treatment of hyperthyroidism. Acta Med Scand 206: 21?25","journal-title":"Acta Med Scand"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/bmj.281.6232.24","volume":"281","author":"P Heyma","year":"1980","unstructured":"Heyma P, Larkins RG, Higginbotham L, Wan Ng K (1980) D-propranolol and DL-propranolol both decrease conversion of L-thyroxine to L-triiodothyronine. Br Med J 281: 24?25","journal-title":"Br Med J"},{"key":"CR33","first-page":"1283","volume":"281","author":"NDS Bax","year":"1980","unstructured":"Bax NDS, Lennard MS, Tucker GT (1980) Effect of beta-blockers on thyroid hormone. Br Med J 281: 1283","journal-title":"Br Med J"},{"key":"CR34","unstructured":"Anonymous (1980) Beta-blockers in thyrotoxicosis. Lancet 1: 184?186"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00542321.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00542321\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00542321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T22:34:19Z","timestamp":1554417259000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00542321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1982]]}},"alternative-id":["BF00542321"],"URL":"https:\/\/doi.org\/10.1007\/bf00542321","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982]]}}}